The Relationship Between Serum 25-hydroxyvitamin D Concentration and Type 2 Diabetic Peripheral Neuropathy: A Systematic Review and a Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2019 Nov 27

PMID 31770239

Citations 8

Authors

Binjie Zhang

Wenli Zhao

Jinli Tu

Xueying Wang

Yu Hao

Hongwu Wang

Ye Zhao

Kaito Mizuno

Yiider Tseng

Huaien Bu

Affiliations

Soon will be listed here.

Abstract

Background: Vitamin D is a fat-soluble vitamin that is related to the health of the human body and is an indispensable nutrient for human beings. Some studies indicated that type 2 diabetes mellitus (T2DM) with diabetic peripheral neuropathy (DPN) may be associated with vitamin D deficiency, but the current understanding of this point of view remains controversial. This study aimed to evaluate the correlation between serum 25-hydroxyl vitamin D (25 [OH] D) concentration and DPN in patients with T2DM by a meta-analysis, and to provide a reference for doctors.

Methods: Relevant studies were selected from the PubMed, Cochrane Library, China National Knowledge Infrastructure, VIP databases, and Wanfang Data Knowledge Service Platform databases dating from 2000 to December 2017. A total of 75 articles related to serum 25 (OH) D and DPN were selected from 2000 to December 2017. Based on the inclusion and exclusion criteria of the literature, a quality assessment was conducted using the Newcastle-Ottawa scale, and a meta-analysis was performed by RevMan5.3 statistical software.

Results: Thirteen studies that involved a total of 2814 type 2 diabetic patients were finally included into the meta-analysis. Meta-analysis results, heterogeneity test showed that, P < .000 01, I = 92%, calculation by random effect model revealed that, the serum concentration of 25 (OH) D in T2DM combined with DPN group was lower than that in the group without DPN (weighted mean difference = -0.74, 95% confidence interval: -1.03 to -0.46) CONCLUSIONS:: Vitamin D is associated with type 2 DPN (DPN), and vitamin D deficiency can lead to an increased risk of type 2 DPN. However, more high-quality research is needed.

Citing Articles

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.

Chen C, Zirpoli G, Barlow W, Budd G, McKiver B, Pusztai L J Natl Compr Canc Netw. 2023; 21(11):1172-1180.e3.

PMID: 37935109 PMC: 10976748. DOI: 10.6004/jnccn.2023.7062.

Neuropathic Pain and its Relationship With Fibromyalgia, Vitamin D Status and Medication Use in Patients With Ankylosing Spondylitis.

Mizrak S, Kirnap M, Cuce I J Rheum Dis. 2023; 28(3):126-132.

PMID: 37475992 PMC: 10324899. DOI: 10.4078/jrd.2021.28.3.126.

Therapeutic effects of dietary antioxidative supplements on the management of type 2 diabetes and its complications; umbrella review of observational/trials meta-analysis studies.

Tabatabaei-Malazy O, Peimani M, Mohseni S, Nikfar S, Abdollahi M, Larijani B J Diabetes Metab Disord. 2022; 21(2):1833-1859.

PMID: 36404841 PMC: 9672207. DOI: 10.1007/s40200-022-01069-1.

Association of vitamin D status with all-cause mortality and outcomes among Chinese individuals with diabetic foot ulcers.

Tang W, Chen L, Ma W, Liu G, Chen D, Wang C J Diabetes Investig. 2022; 14(1):122-131.

PMID: 36200877 PMC: 9807158. DOI: 10.1111/jdi.13917.

Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy.

Okdahl T, Brock C Curr Diab Rep. 2021; 21(9):31.

PMID: 34448953 PMC: 8397661. DOI: 10.1007/s11892-021-01397-1.

References

Feldman D, Krishnan A, Swami S, Giovannucci E, Feldman B . The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014; 14(5):342-57. DOI: 10.1038/nrc3691. View

Lee P, Chen R . Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med. 2008; 168(7):771-2. DOI: 10.1001/archinte.168.7.771. View

Heaney R . Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004; 80(6 Suppl):1706S-9S. DOI: 10.1093/ajcn/80.6.1706S. View

Maffi P, Secchi A . The Burden of Diabetes: Emerging Data. Dev Ophthalmol. 2017; 60:1-5. DOI: 10.1159/000459641. View

Basit A, Abdul Basit K, Fawwad A, Shaheen F, Fatima N, Petropoulos I . Vitamin D for the treatment of painful diabetic neuropathy. BMJ Open Diabetes Res Care. 2016; 4(1):e000148. PMC: 4800070. DOI: 10.1136/bmjdrc-2015-000148. View

Peltier A, Goutman S, Callaghan B . Painful diabetic neuropathy. BMJ. 2014; 348:g1799. DOI: 10.1136/bmj.g1799. View

Soderstrom L, Johnson S, Diaz V, Mainous 3rd A . Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES. Diabet Med. 2011; 29(1):50-5. PMC: 3461835. DOI: 10.1111/j.1464-5491.2011.03379.x. View

Issa C . Vitamin D and Type 2 Diabetes Mellitus. Adv Exp Med Biol. 2017; 996:193-205. DOI: 10.1007/978-3-319-56017-5_16. View

Grote C, Wright D . A Role for Insulin in Diabetic Neuropathy. Front Neurosci. 2017; 10:581. PMC: 5179551. DOI: 10.3389/fnins.2016.00581. View

10.

Van Belle T, Gysemans C, Mathieu C . Vitamin D and diabetes: the odd couple. Trends Endocrinol Metab. 2013; 24(11):561-8. DOI: 10.1016/j.tem.2013.07.002. View

11.

Palomer X, Gonzalez-Clemente J, Blanco-Vaca F, Mauricio D . Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008; 10(3):185-97. DOI: 10.1111/j.1463-1326.2007.00710.x. View

12.

Putz Z, Martos T, Nemeth N, Korei A, Szabo M, Vagi O . [Vitamin D and neuropathy]. Orv Hetil. 2013; 154(51):2012-5. DOI: 10.1556/OH.2013.29769. View

13.

Ahmadieh H, Azar S, Lakkis N, Arabi A . Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications. ISRN Endocrinol. 2013; 2013:641098. PMC: 3819758. DOI: 10.1155/2013/641098. View

14.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

15.

Alamdari A, Mozafari R, Tafakhori A, Faghihi-Kashani S, Hafezi-Nejad N, Sheikhbahaei S . An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects. Neurol Sci. 2015; 36(7):1121-6. DOI: 10.1007/s10072-015-2207-0. View

16.

Pradeepa R, Mohan V . Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. Eur J Clin Nutr. 2017; 71(7):816-824. DOI: 10.1038/ejcn.2017.40. View

17.

Lv W, Zhao W, Gong S, Fang D, Wang B, Fu Z . Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J Endocrinol Invest. 2014; 38(5):513-8. DOI: 10.1007/s40618-014-0210-6. View

18.

Roman-Pintos L, Villegas-Rivera G, Rodriguez-Carrizalez A, Miranda-Diaz A, Cardona-Munoz E . Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function. J Diabetes Res. 2017; 2016:3425617. PMC: 5183791. DOI: 10.1155/2016/3425617. View

19.

Bell D . Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic Patient. Case Rep Endocrinol. 2013; 2012:165056. PMC: 3530756. DOI: 10.1155/2012/165056. View

20.

Shehab D, Al-Jarallah K, Abdella N, Mojiminiyi O, Al Mohamedy H . Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract. 2015; 24(3):250-6. PMC: 5588231. DOI: 10.1159/000375304. View